HiSiaddi is an innovative foreign trade service provider driven by both technology transformation and foreign trade business. We have established a "1+2+3+4=1" service system and can supply BINAP sourced directly from multiple well-known original manufacturers. As a R&D-oriented foreign trade enterprise, HiSiaddi has repeatedly collaborated with manufacturers on technology transfer and conducted multiple rounds of on-site inspections of BINAP manufacturers, gaining objective and in-depth insights into various brands. We regularly analyze BINAP manufacturers for clients to help them select suitable products. Below is a brand recommendation case.
Contact HiSiaddi customer service for more brand and model comparison analysis.
The client is a high-end pharmaceutical CDMO based in Munich, Germany, specializing in custom manufacturing of anti-cancer and anti-viral APIs and serving the world’s top 20 pharmaceutical companies. All production lines hold FDA, EMA, and GMP certifications, representing a typical technology-driven mid-to-high-end client. The client purchases 80 kg of high-purity chiral BINAP (R/S configuration) annually for core chiral catalytic reactions. It previously sourced Takasago (Japan) products exclusively, but switched to Chinese suppliers in 2025 due to a 25% price increase and extended lead times of up to 12 weeks.
Client Pain Points: The client has zero familiarity with China’s BINAP brand landscape, technical tiers, and model differences. It contacted five leading domestic manufacturers – Runyu, Funokang, Jixinyibang, Yuanda, and Kelaman – each of which only promoted its own products, highlighting internal advantages without objective commentary on competitors’ technical strengths and applicable scenarios. This lack of horizontal comparison data stalled procurement decision-making, as the client feared quality risks from improper brand selection. The client authorized HiSiaddi to deliver neutral brand evaluations and model selection solutions.
As a European high-end client relying long-term on Japanese and Korean imports, the client has no understanding of China’s three-tier BINAP industry structure (top-tier mid-high-end, mid-tier, entry-level). It cannot distinguish technical gaps between brands in purity, chiral resolution, impurity control, and pharmaceutical-grade compliance, risking misleading information from one-sided manufacturer promotions.
The five manufacturers are mainstream domestic BINAP producers, yet all adopt a "self-promotion only, no competitor evaluation" strategy:
· Runyu: Emphasizes leading chiral resolution technology and stable ee values, without mentioning Funokang’s high-purity purification advantages.
· Funokang: Highlights 99.95% ultra-high purity and low heavy metals, without referencing Runyu’s cost-effective industrial-grade products.
· Jixinyibang: Stresses customizable particle sizes and flexible production, without comparing Kelaman’s research-grade quality.
· Yuanda: Highlights large production capacity and fast lead times, without disclosing its lower purity relative to top-tier brands.
· Kelaman: Focuses on small-batch research-grade production and strict impurity control, without mentioning high mass production costs.
The client lacks horizontal comparison data, applicable scenario analysis, and real downstream customer cases, creating no reliable basis for procurement decisions and raising risks of substandard purity, unstable chiral configuration, or excess impurities disrupting pharmaceutical production compliance.
Explicit client specifications: Purity ≥99.8%, ee value ≥99.5%, heavy metals ≤0.5 ppm, moisture ≤100 ppm, complete GMP/REACH/COA documentation, compatibility with pharmaceutical-grade catalytic reactions, and rejection of low-end industrial-grade products. The client targets mature mid-to-high-end brands and models balancing qualified technical performance, stable supply, and cost optimization.
HiSiaddi conducted neutral blind testing, on-site factory verification, and downstream client research across seven core dimensions – purity, chiral resolution, impurity control, compliance documentation, capacity & lead time, applicable scenarios, and price range – to generate an objective comparison report. Key details are as follows:
Core strengths: Domestic leader in chiral resolution technology, stable ee value ≥99.6%, strong mass production capacity (monthly output 50 kg), comprehensive pharmaceutical-grade compliance. Main models:
· R-BINAP-998: Purity 99.8%, ee value 99.6%, heavy metals ≤0.5 ppm – flagship pharmaceutical-grade model
· S-BINAP-995: Purity 99.5%, ee value 99.5% – for general asymmetric catalysis
· rac-BINAP-990: Purity 99.0% – cost-effective industrial-grade racemate Applicable scenarios: Pharmaceutical APIs, high-end chiral catalysis, processes with strict ee value requirements Price range: Mid-to-high-end (20% lower than Japanese alternatives)
Core strengths: Leading ultra-high-purity purification technology, purity up to 99.95%, heavy metals ≤0.3 ppm, thorough removal of trace impurities. Main models:
· FNK-R-BINAP-9995: Purity 99.95%, ee value 99.7%, heavy metals ≤0.3 ppm – flagship ultra-pure pharmaceutical grade
· FNK-R-BINAP-998: Purity 99.8%, ee value 99.6% – general high-purity grade
· FNK-rac-BINAP-992: Purity 99.2% – high-purity industrial grade Applicable scenarios: High-end anti-cancer and anti-viral drugs, catalytic reactions sensitive to trace impurities Price range: High-end (slightly higher than Runyu, 15% lower than Japanese alternatives)
Core strengths: Customizable particle sizes (5–50 μm adjustable), flexible small-batch production, moderate pricing. Main models:
· JXYB-R-BINAP-995: Purity 99.5%, ee value 99.4% – customizable particle size grade
· JXYB-rac-BINAP-990: Purity 99.0% – customizable industrial grade Applicable scenarios: Fine chemicals requiring moderate purity and specific particle sizes, general pharmaceutical intermediates Price range: Mid-tier (high cost performance)
Core strengths: Large capacity (monthly output 100 kg), short lead times (2 weeks), low pricing. Main models:
· YD-rac-BINAP-990: Purity 99.0%, no ee value requirements – primary industrial grade
· YD-R-BINAP-992: Purity 99.2%, ee value 99.0% – entry-level chiral grade Applicable scenarios: Industrial catalysis, general fine chemicals, processes with loose purity standards Price range: Entry-level (lowest price bracket)
Core strengths: Research-grade quality control, small-batch customization (1–5 kg), comprehensive impurity testing, suitable for pharmaceutical R&D and universities. Main models:
· KLM-R-BINAP-998: Purity 99.8%, ee value 99.6% – high-purity research grade
· KLM-S-BINAP-995: Purity 99.5%, ee value 99.5% – dedicated R&D grade Applicable scenarios: New drug R&D, lab and pilot scale trials, scientific research projects Price range: High-end (premium pricing for small batches)
· Tier 1 (Mid-to-High-End, Pharmaceutical-Grade Compatible): Runyu, Funokang (technically qualified, full compliance, stable supply – aligned with German client requirements)
· Tier 2 (Mid-Tier, General Fine Chemical Compatible): Jixinyibang (strong customization yet insufficient purity for pharmaceutical standards)
· Tier 3 (Entry-Level, Industrial-Grade Compatible): Yuanda, Kelaman (Yuanda lacks sufficient purity; Kelaman has limited mass production capacity – neither matches client demands)
Eliminating mid-tier and entry-level brands based on the client’s five core demands (pharmaceutical-grade purity, stable chirality, low impurities, complete compliance, stable mass supply), HiSiaddi focused on Tier 1 and recommended two mid-to-high-end brands and three core models with clear applicable scenarios and advantages:
Recommended Model: R-BINAP-998 Core Advantages:
· Purity 99.8%, ee value 99.6%, fully meeting pharmaceutical-grade catalytic standards
· Heavy metals ≤0.5 ppm, moisture ≤90 ppm, complying with USP standards
· Stable monthly capacity of 50 kg, 4-week lead time matching the client’s 80 kg annual demand
· Complete GMP, REACH, COA, and DMF documentation with EMA filing approval
· 20% lower pricing than Japanese alternatives for optimal cost performance
Recommended Models: FNK-R-BINAP-9995 (Ultra-Pure Flagship) & FNK-R-BINAP-998 (General High-Purity) Core Advantages:
· FNK-R-BINAP-9995: Purity 99.95%, ee value 99.7%, heavy metals ≤0.3 ppm – for high-end anti-cancer drug manufacturing with impurity control exceeding industry norms
· FNK-R-BINAP-998: Purity 99.8%, ee value 99.6%, equivalent grade to Runyu as backup alternative
· Thorough removal of trace impurities (residual solvents, halogens), passing FDA impurity limit audits
· Complete SGS test reports and full-batch traceability documentation satisfying high-end API filing requirements
· Eliminate low-tier brands: Yuanda’s insufficient purity and Kelaman’s limited mass production capacity fail to meet pharmaceutical-grade production stability and compliance standards.
· Lock Tier 1 brands: Runyu and Funokang are China’s only two manufacturers with stable mass production capacity for pharmaceutical-grade BINAP, delivering qualified technology, complete compliance, and reliable supply.
· Tiered model matching:
o General API manufacturing: Runyu R-BINAP-998 (optimal comprehensive performance & cost efficiency)
o High-end anti-cancer/anti-viral drugs: Funokang FNK-R-BINAP-9995 (ultra-low impurities compatible with highly sensitive catalytic reactions)
o Backup/general applications: Funokang FNK-R-BINAP-998 (equivalent-grade alternative for supply redundancy)
The client highly recognized HiSiaddi’s neutral, data-driven brand evaluation report, stating it "broke down manufacturer information barriers, clearly outlined technical differences and applicable scenarios across brands, and resolved core procurement selection pain points". Final procurement decision:
· Primary procurement: Runyu R-BINAP-998 (60 kg/year) for general API production
· High-end production line procurement: Funokang FNK-R-BINAP-9995 (20 kg/year) for anti-cancer drug manufacturing
· Initial order: 30 kg (20 kg Runyu + 10 kg Funokang) with 4-week lead time
Full incoming testing of the initial batch confirmed all indicators qualified:
· Runyu R-BINAP-998: Purity 99.82%, ee value 99.65%, heavy metals 0.4 ppm – fully compliant
· Funokang FNK-R-BINAP-9995: Purity 99.96%, ee value 99.72%, heavy metals 0.25 ppm – exceeding agreed standards Production validation after introduction to API manufacturing lines showed catalytic efficiency and end-product chiral purity identical to Japanese imported goods, with zero quality issues and full compatibility with pharmaceutical-grade production.
The client’s Procurement Director commented: "As a high-end pharmaceutical enterprise, we prioritize authentic, neutral information over self-promotional manufacturer pitches. HiSiaddi clarified China’s BINAP brand landscape and delivered precise brand and model recommendations aligned with our production requirements, eliminating selection risks. The delivered products fully meet quality standards while cutting costs by 18%, making HiSiaddi a trusted strategic partner."
Subsequent Cooperation: The client awarded HiSiaddi the full 80 kg annual BINAP order and entrusted additional high-end customization demands including S-BINAP and sulfonated BINAP to HiSiaddi’s integrated solution covering brand selection, technical coordination, quality control supervision, and compliance services. A 3-year framework cooperation agreement was signed.
Core pain point of high-end clients: Blank awareness of domestic Chinese brands, asymmetric information from self-serving manufacturers creating a lack of neutral reference for procurement selection. Primary demands include precise matching, stable reliability, and complete compliance rather than low pricing alone.
HiSiaddi core value: Acting as a neutral technical consultant rather than a brand salesperson, breaking information barriers via full-dimensional evaluations and delivering tiered recommendations tailored to client requirements to mitigate selection risks and build trust.
Core logic for brand selection: Mid-to-high-end clients must focus on Tier 1 brands with qualified technology, complete compliance, and stable supply, matching models precisely to application scenarios (general vs. high-end) to balance quality, cost, and stability.
Industry insight: Professional, neutral, data-driven brand evaluation and model selection services differentiate HiSiaddi from ordinary traders and constitute core competitiveness for serving high-end fine chemical and pharmaceutical clients, enabling unimpeded access to high-end cross-border supply chains and long-term cooperative relationships.
Contact HiSiaddi customer service for more brand and model comparison analysis.
+86-13120989737 
info@hisiaddi.com 
English
